The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

The Oncology Institute, Inc.NASDAQ: TOI

Operating Margin · Q1 FY2026 · quarter ended Mar 2026

Operating margin widens to -4.4%

Operating margin was -4.4% in Q1 FY2026, up 5.1 pp from a year earlier. On a trailing-twelve-month basis it was -6.0%, up 6.9 pp year over year. Over 3 fiscal years it widened by 25.3 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 3 analysts of -18.8% for the fiscal year ending Dec 2026, down from -7.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-4.4%+0.4 pp QoQ
Last fiscal yearDec 2025
-7.2%+8.1 pp YoY
LTMMar 2026
-6.0%+6.9 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.1 pp-9.4 pp-14.5 pp
1 year+8.1 pp-11.6 pp-19.7 pp
3 years+25.3 pp-11.6 pp-36.9 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-7.2%
Year-over-year change
+8.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How TOI compares with its peers on the latest reported figures

  • TOI's LTM Mar 2026 operating margin of -6.0% is the 3rd highest of the 10 companies compared; the peer median is -12.1%.
  • Its year-over-year change of +6.9 pp is the 2nd highest of 10, against a peer median of -1.6 pp.
  • Over three fiscal years its change of +25.3 pp compares with a peer median of +4.5 pp.
TOI Competitors Peer median
Operating Margin for TOI and competitors
Company Period LTM level YoY 3-year change
AUNAAuna S.A.LTM Mar 202614.1% -2.5 pp+4.5 pp
CCRNCross Country Healthcare, Inc.LTM Mar 2026-2.1% -0.4 pp-10.0 pp
TOIThe Oncology Institute, Inc.LTM Mar 2026-6.0% +6.9 pp+25.3 pp
AGLAgilon Health, Inc.LTM Mar 2026-6.8% -1.6 pp-2.7 pp
EOLSEvolus, Inc.LTM Mar 2026-9.6% +5.2 pp+31.3 pp
KIDSOrthoPediatrics Corp.LTM Mar 2026-12.1% +5.0 pp+8.5 pp
SNDASonida Senior Living, Inc.LTM Mar 2026-20.5% -16.1 pp-3.0 pp
TMCITreace Medical Concepts, Inc.LTM Mar 2026-26.9% -2.1 pp-0.9 pp
CBLLCeriBell, Inc.LTM Mar 2026-68.3% -4.3 pp+73.4 pp
AUTLAutolus Therapeutics plcLTM Mar 2026-285.9% +4535.6 pp+1934.5 pp
Peer median (excluding TOI) -12.1%-1.6 pp+4.5 pp

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue203M252.48M324.24M393.41M502.73M
Cost of Revenue162.16M200.39M264.67M339.42M426.29M
Gross Profit40.85M52.09M59.57M54M76.44M
Gross Margin20.1%20.6%18.4%13.7%15.2%
Research & Development00000
Selling, General & Admin0000105.57M
Operating Expenses86.71M134.04M136.59M114.12M112.52M
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
EBITDA(42.04M)(67.6M)(54.28M)(50.88M)(42.52M)
EBITDA Margin-20.7%-26.8%-16.7%-12.9%-8.5%
Operating Income(45.86M)(81.95M)(77.02M)(60.12M)(36.08M)
Operating Margin-22.6%-32.5%-23.8%-15.3%-7.2%
Interest Income00000
Interest Expense320K4.08M6.78M7.5M11.28M
Other Income / Expenses34.26M81.86M(6.09M)(4.55M)(24.65M)
Income Before Tax(11.6M)(91K)(83.1M)(64.66M)(60.74M)
Pre-Tax Margin-5.7%-0.0%-25.6%-16.4%-12.1%
Income Tax Expense(671K)(243K)(36K)0(131K)
Net Income(10.93M)152K(83.07M)(64.66M)(60.61M)
Net Margin-5.4%0.1%-25.6%-16.4%-12.1%
EPS (Basic)(0.16)0.00(0.92)(0.71)(0.54)
EPS (Diluted)(0.16)(0.21)(0.92)(0.71)(0.54)
Weighted Avg Shares66.23M72.79M73.75M75.04M923.89M
Weighted Avg Shares (Diluted)66.23M80.61M73.75M75.04M923.89M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.